Not Signed In - Access Pharmaceuticals Announces Presentation Of ProLindac(TM) Data At International Conference
Thu, 22 Feb 2007 08:00 AM EST
... Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) announced today that recent clinical data for ProLindac(TM), its novel DACH platinum polymer prodrug, is being presented at the International Symposium on Polymer Therapeutics at the Freie Universitat Berlin, in Germany. Following encouraging Phase I clinical results, ProLindac(TM) is currently in two Phase II studies. [click link for full article] ...
Related Topics
- Data & Statistics
- Data Analysis
- Health Care Access
- National Data
- International Health
- Chemical Safety
- Child Abuse And Neglect
- Logging
- Mining
- Bloodborne Pathogens
- Hemodialysis
- Vascular Access for Hemodialysis
- Migration
- Psychopharmacology
- Peritoneal Dialysis
- Visualization
- International Classification of Diseases
- Influenza Surveillance Data
- Universal Data Collection Updates
- Hospital Data / Inpatient Care
email this page
print this page
bookmark this page
feedback on this page
